Shilpa Medicare Ltd share price
Shilpa Medicare Ltd (SHILPAMED) is a stock listed on India's exchanges (NSE & BSE). On Traddx you can view its live price, interactive candlestick charts with 20/50/200-day moving averages and golden/death-cross detection, quarterly results, analyst price targets, peer comparison, and the smart-money signal โ which star investors hold it and who is buying it on today's bulk/block deals tape.
Shilpa Medicare Limited value chain โ customers, suppliers & competitors
Shilpa Medicare Limited manufactures specialized active pharmaceutical ingredients (APIs), chemical intermediates, and complex formulations, while also providing contract manufacturing services. It sits in the mid-stream of the pharma supply chain, turning raw chemicals into specialized medicines for global markets.
๐ Customers โ who buys from Shilpa Medicare Limited
- Global pharmaceutical marketing companies โ Finished formulations and oncology APIs
โ๏ธ Suppliers โ raw materials & inputs
- Basic chemical and petrochemical suppliers โ Solvents, reagents, and raw chemical intermediates
- Specialty packaging material vendors โ Vials, ampoules, and specialized packaging for injectables
โ๏ธ Competitors โ other sellers
- Lupin Limited โ Competes in complex formulations and global generic markets, but operates on a much larger scale.
- Supriya Lifescience Limited โ Competes directly in specialized active pharmaceutical ingredients (APIs) and niche therapeutic segments.
- Ind-Swift Laboratories โ Competes in the API manufacturing and pharmaceutical intermediates space.
๐ Other suppliers to its customers
- Other large Indian and global CDMOs โ Global pharma buyers often dual-source complex injectables and APIs from alternative contract manufacturers.
๐ค Peers that share its suppliers
- Supriya Lifescience Limited โ Shares similar raw material sourcing channels for chemical intermediates and solvents.
- Lupin Limited โ Procures similar upstream specialty chemicals and regulatory-grade packaging materials.
This value-chain map is AI-researched from public sources; company links and any figures are estimates, not official company disclosures. Not investment advice.